Bolt Biotherapeutics, Inc. Restricted Cash, Current
Bolt Biotherapeutics, Inc. (BOLT) had Restricted Cash, Current of $200.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2026-08-11
- 2026-06-30: Restricted Cash, Current $200.00K.
- 2026-03-31: Restricted Cash, Current $200.00K.
- 2025-12-31: Restricted Cash, Current $200.00K.
- 2025-09-30: Restricted Cash, Current $784.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $200.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $784.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $784.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $784.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $784.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $792.00K 10-Q · filed 2024-11-12 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |